First United Bank & Trust »

Crispr Therapeutics shares owned by First United Bank & Trust

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by First United Bank & Trust from 13F filings

Historical chart of First United Bank & Trust investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by First United Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by First United Bank & Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.8k 100 68.16
2023-12-31 $6.3k 100 62.60

More positions owned by First United Bank & Trust

Invesco QQQ Unit Series 1 Unit Ser 1 (QQQ)
Vanguard Value ETF Value Etf (VTV)
Apple (AAPL)
Vanguard Index FDS S&P 500 ETF S&p 500 Etf Shs (VOO)
Vanguard Growth ETF Growth Etf (VUG)
Microsoft Corporation (MSFT)
iShares Select Dividend ETF Select Divid Etf (DVY)
Flexshares Stoxx US ESG Impact Index Stox Us Esg Slct (ESG)
Invesco S&P 500 Garp ETF S&p 500 Garp Etf (SPGP)
Vanguard Index FDS McAp GR Idxvip Mcap Gr Idxvip (VOT)
Invesco S&P 500 Equal Weight S&p500 Eql Wgt (RSP)
Erie Indty Co CL A Cl A (ERIE)
Lowe's Companies (LOW)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for First United Bank & Trust

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics